Carelane

69 days to build. 29 to amend. 36 to lock. Those are the industry averages for CROs. If you can't say where you land against them, the sponsor will assume you land on them. That assumption is being made in a bid right now.

A question every CROS should ask before the next bid: what is the median time from contract execution to first patient in, across the last ten studies? If that answer takes three weeks to assemble out of five systems, a shared drive and a project manager's memory, you don't just have a measurement problem. You have an architecture problem. And the bid doesn't fail in the defence - it fails months earlier, in whatever systems you are running

"Agile." "Responsive." "Close to our sites." Sponsors have read those in every proposal they have ever received, including the global giant's. Nothing in them can be checked, so the decision falls back to scale. Scale is an arena in which no mid-size CRO wins. Proof looks different. Which hard numbers do you need to bring to the table to win the next bid? Check out the article.

Five systems. The same five steps. Two very different timelines. The difference isn't that anyone works faster. It's that nobody waits at the handoff, because there is no handoff. The work is identical. The waiting is what the sponsor pays for.

Every sponsor has read a status report and wondered what didn't make it in. So stop sending the report. Offer read access to the live numbers instead: activation by site, open queries and their age, build and amendment turnaround. On demand, in the system, with nobody preparing anything first. It costs nothing, provided the numbers are good - and your software can supply them. Carelane can.

Mid-size CROs bid against the global players every week. Here's the part of that comparison worth being honest about. Scale, brand, perceived security - the global CRO wins those, no questions asked. What you have is the trade-off that comes with it. A 60-country operating model is built for consistency, not for turning quickly. Study startup, amendments, mid-study changes: that's where weeks vs. quarters gets decided. And unlike a logo on a slide, speed is something the sponsor experiences every day the trial is running. You can’t out-scale them. Out-evidence them - cycle times, amendment turnaround, FPI. In writing, in the bid.